article thumbnail

A different approach: reimagining biology

Drug Discovery World

Three key members of the team – Dr Raquel Sanches-Kuiper, Vice President of Technology, Dr Matthew Hayes, Chief Technology Officer and John Edgell, Head of Cloud Engineering – explain how the company is doing this and what it means for the advancement of DNA synthesis in the lab. The next goal is to optimise the technology. “At

DNA 130
article thumbnail

Tuesday 18 April at AACR Annual Meeting 2023

Drug Discovery World

Riccardo Dalla-Favera, a Fellow of the AACR Academy, is Director of the Institute for Cancer Genetics; the Percy and Joanne Uris Professor of Clinical Medicine; Professor of Pathology and Cell Biology, Microbiology and Immunology, and Genetics and Development; and member of the Herbert Irving Comprehensive Cancer Center at Columbia University.

DNA 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Sitting down with… Neil Dhawan

Drug Discovery World

ND : Totus has innovated three interdependent and fundamental technologies in chemistry, biology, and AI to enable screening of billions of candidate molecules against hundreds of targets in parallel. Second, we have created a novel DNA-tracking technology to analyse billions of molecular interaction in a cellular setting.

article thumbnail

How to advance AAV-based gene therapies

Drug Discovery World

in Cell Biology and Biochemistry from University College London and was a post-doctoral fellow at Albert Einstein College of Medicine in New York City. Such therapies have become an appealing drug modality for multiple conditions, including monogenic disorders, cancers, and infectious diseases. She received a Ph.D. References 1: U.S.

Therapies 162
article thumbnail

How nucleolar stress accelerates aging in mice

Drug Target Review

For his postdoctoral stay he joined the group of André Nussenzweig, where he started to work on DNA repair, particularly focusing on the role of histone H2AX. In 2005, he joined CNIO to lead the Genomic Instability Group where he has been ever since.

RNA 64
article thumbnail

#WhyIScience Q&A: A cell biologist now helps recent college graduates launch their scientific careers

Broad Institute

in cell biology. During graduate school at MIT and the Whitehead Institute, my interest in cell division came full circle and I was able to explore how a cell divides to make two cells that are genetically identical. Each cell needs the same amount of DNA so they can function like each other.

Science 111
article thumbnail

Cell and gene therapy development moves into cardiac indications

Drug Target Review

For example, integrating gene therapies that alter the DNA of cardiac cells pose risks of unintended genetic modifications, which could lead to tumorigenesis. Continued growth in the field relies on multidisciplinary efforts combining biology, engineering, and clinical medicine.